Contact this trialFirst, we need to learn more about you.
Topoisomerase I inhibitors
Irinotecan +1 More for Gastroesophageal Junction Adenocarcinoma
Recruiting1 awardPhase 2
Saint Louis, Missouri
This trial will study the safety and effectiveness of a combination of drugs for people with stomach or gastro-esophageal junction cancer who have not responded to first-line chemotherapy.
Fill-in a few details and create your profileHaving a profile will help us send you recommended trials and speed up your application in the future.
We will keep your details privateWe won’t share unless you give us permission. By completing this form you agree to our privacy policy
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.